6 August, 2021 by The TZ Newswire Staff Comments Off on Cronos Group Reports 2021 Second Quarter Results
Cronos Group Reports 2021 Second Quarter Results
Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids
6 August, 2021 by The TZ Newswire Staff Comments Off on DT Midstream Reports Strong Second Quarter 2021 Results
DT Midstream Reports Strong Second Quarter 2021 Results
DETROIT, Aug. 06, 2021 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) today announced second quarter 2021 reported net income of $68 million, or $0.70 per diluted share. For the second quarter of 2021, operating earnings were $89 million and adjusted EBITDA was $191 million.
6 August, 2021 by The TZ Newswire Staff Comments Off on InflaRx to Present at the BTIG Virtual Biotechnology Conference
InflaRx to Present at the BTIG Virtual Biotechnology Conference
JENA, Germany, Aug. 06, 2021 (GLOBE NEWSWIRE) — InflaRx (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, will present at the BTIG Virtual Biotechnology Conference on August 10.
6 August, 2021 by The TZ Newswire Staff Comments Off on Avis de conférence téléphonique de Thérapeutique Knight sur ses résultats du deuxième trimestre 2021
Avis de conférence téléphonique de Thérapeutique Knight sur ses résultats du deuxième trimestre 2021
MONTRÉAL, 06 août 2021 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (ex. EU) et chef de file, publiera ses résultats financiers du deuxième trimestre 2021, ce vendredi 13 août 2021 avant l’ouverture du marché. À la suite de cette publication, Knight sera l’hôte d’une conférence téléphonique et d’une webémission. Knight invite cordialement toutes les parties intéressées à participer à cet appel.
6 August, 2021 by The TZ Newswire Staff Comments Off on Notice of Knight Therapeutics’ Second Quarter 2021 Results Conference Call
Notice of Knight Therapeutics’ Second Quarter 2021 Results Conference Call
MONTREAL, Aug. 06, 2021 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2021 financial results on Friday, August 13, 2021 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call.
6 August, 2021 by The TZ Newswire Staff Comments Off on Ocuphire Pharma Presenting at Two Conferences in August
Ocuphire Pharma Presenting at Two Conferences in August
Canaccord Genuity 41st Annual Growth Conference being held virtually on August 10-12, 2021
6 August, 2021 by The TZ Newswire Staff Comments Off on Life Clips’ Cognitive Apps To Release Aiki, AI-Based Intuitive Mental Health ChatBot
Life Clips’ Cognitive Apps To Release Aiki, AI-Based Intuitive Mental Health ChatBot
Aiki delivers CBT and IPT therapies using chatbot which also includes the Yuru voice analysis solution that takes in other health data from apple and google HealthKit to make a more accurate analysis of one’s mental health. Aiki delivers CBT and IPT therapies using chatbot which also includes the Yuru voice analysis solution that takes in other health data from apple and google HealthKit to make a more accurate analysis of one’s mental health.